Literature DB >> 33309330

[Classification of vascular tumours and vascular malformations. Contribution of the ISSVA 2014/2018 classification].

Michel Wassef1, Michel Borsik2, Pierre Cerceau3, Benoit Faucon4, Claude Laurian5, Nicolas Le Clerc6, Françoise Lemarchand-Venencie7, Claudine Massoni8, Didier Salvan9, Annouk Bisdorff-Bresson7.   

Abstract

The study of vascular anomalies, "angiomas", vascular tumours and vascular malformations is made difficult by the great variety and confusion of the names used in the literature for these diseases, some of which are rare. The great merit of the classification proposed by the International Society for the Study of Vascular Anomalies (ISSVA), adopted in 2014 and modified in 2018, is to propose a unambiguous nomenclature and to try to group these lesions in a logical way, contrasting with the lists of the usual "classifications". This classification is based on the distinction between proliferative lesions (tumours and reactive lesions) and those which are due to a congenital anomaly of vascular morphogenesis (vascular malformations). It incorporates recent data on the molecular causes of these diseases. The major groups of lesions recognised in this classification will be presented and some lesions of interest briefly discussed. This classification aims to be usable by all medical specialties and applicable to all tissues and organs, even if efforts are still needed to integrate organ-specific names in order to unify the nomenclature and eliminate confusion. Even if it does not solve all the problems in this complex field, the unification of the nomenclature is a major contribution of this classification and pathologists are strongly encouraged to refer to it in daily practice.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Angiomas; Angiomes; Anomalies vasculaires; Classification; ISSVA; Malformations vasculaires; Nomenclature; Tumeurs vasculaires; Vascular anomalies; Vascular malformations; Vascular tumours

Year:  2020        PMID: 33309330     DOI: 10.1016/j.annpat.2020.11.004

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  5 in total

1.  Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series.

Authors:  Anna Karastaneva; Paolo Gasparella; Sebastian Tschauner; Roman Crazzolara; Gabriele Kropshofer; Manfred Modl; Andreas Pfleger; Ante Burmas; Mirjam Pocivalnik; Raphael Ulreich; Werner Zenz; Wolfgang Schwinger; Besiana P Beqo; Christian Urban; Emir Q Haxhija; Herwig Lackner; Martin Benesch
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

2.  Case Report: Congenital Intracranial Kaposiform Hemangioendothelioma Treated With Surgical Resection.

Authors:  Yingjie Cai; Jiayi Li; Wei Yang; Nan Zhang; Hailang Sun; Weiping Zhang; Ming Ge
Journal:  Front Surg       Date:  2022-04-01

3.  Angiographic Embolization with Histoacryl in Combination with Direct Injection of Bone Cement of an Intraosseous Venous Malformation of the Mandible: Report of a Case with 22-Year Follow-Up.

Authors:  Antoine Berberi; Georges Aoun; Georges Aad; Saad Khairallah; Ghassan Abi Chedid
Journal:  Case Rep Vasc Med       Date:  2022-02-16

Review 4.  Imaging of peripheral vascular malformations - current concepts and future perspectives.

Authors:  Vanessa F Schmidt; Max Masthoff; Michael Czihal; Beatrix Cucuruz; Beate Häberle; Richard Brill; Walter A Wohlgemuth; Moritz Wildgruber
Journal:  Mol Cell Pediatr       Date:  2021-12-07

5.  Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series.

Authors:  Changhua Wu; Dan Song; Lei Guo; Liang Wang
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.